The second technology appraisal committee meeting took place on 14 December 2023. Existing patients and new patients who start treatment while the NICE evaluation is ongoing will continue to have access to the treatments after NICE has issued its final recommendations irrespective of the outcome. NICE will be liaising with key stakeholders to determine the most appropriate next steps and will provide an update in January 2024. Further details can be found here:
https://www.nice.org.uk/guidance/gid-ta11187/documents/supporting-documentation